Extracorporeal photopheresis (ECP) has gained importance in the treatment of several
diseases. Initially introduced as a new therapeutic modality for the treatment of patients with …

This synopsis reviews recent developments in dermatological phototherapy. UVA1
phototherapy (340-400 nm) is effective in the treatment of inflammatory skin diseases such …

Extracorporeal photopheresis (ECP) is a technique that was developed> 20 years ago to
treat erythrodermic cutaneous T‐cell lymphoma (CTCL). The technique involves removal of …

Extracorporeal photopheresis (ECP) is a combination of leukapheresis and photodynamic
therapy in which blood is treated with photoactivable drugs which are then activated with …

Extracorporeal photochemotherapy (extracorporeal photopheresis, ECP) is going to become
a new alternative in the treatment of cutaneous T cell lymphomas (CTCL), autoimmune …

Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …

Extracorporeal photochemotherapy (ECP), also known as extracorporeal photopheresis,
initially demonstrated a therapeutic impact on cutaneous T-cell lymphoma (CTCL) in the trial …

Background After the first investigational study on the use of extracorporeal photopheresis
for the treatment of cutaneous T‐cell lymphoma was published in 1983 with its subsequent …

Extracorporeal photochemotherapy or photopheresis is an immunomodulatory therapy that
combines leukapheresis with phototherapy. Blood from the patient is processed to give a …

Photopheresis or extracorporeal photochemotherapy (ECP) is a novel immunomodulatory
therapy which involves separation of the patient's leucocyte‐rich plasma, followed by ex vivo …